ColgatePalmolive (CL)
(Delayed Data from NYSE)
$99.04 USD
-0.93 (-0.93%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $98.65 -0.39 (-0.39%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$99.04 USD
-0.93 (-0.93%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $98.65 -0.39 (-0.39%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth F Momentum D VGM
Zacks News
Church & Dwight (CHD) Shares Up 21.9% YTD: What's Driving It?
by Zacks Equity Research
Church & Dwight (CHD) gains from its strength across end markets, acquired assets, its solid online channel and shareholder-friendly policies.
Why You Must Consider Colgate (CL) Stock Before Q2 Earnings
by Zacks Equity Research
Colgate (CL) is well-poised on its innovation efforts, pricing actions, digital capabilities and progress on revenue growth management initiatives.
Implied Volatility Surging for Colgate-Palmolive (CL) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Colgate-Palmolive (CL) stock based on the movements in the options market lately.
Colgate (CL) Looks Solid on Pricing Action & Expansion Strategy
by Zacks Equity Research
Pricing actions, revenue management initiatives, innovation, brand strength and digital growth position Colgate (CL) for growth amid higher costs and currency headwinds.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
5 Soaps & Cleaning Materials Stocks to Gain in a Prospering Industry
by Rajani Lohia
The soap and cleaning materials industry is positioned to gain from revived demand trends, pricing actions, innovation, digital transformation and brand building, while elevated costs remain headwinds. Players like PG, CL, RBGLY, CHD and CLX look well-poised.
Colgate-Palmolive (CL) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
Colgate (CL) Rises 5% in the Past Three Months: Here's How
by Zacks Equity Research
Despite rising raw material costs, Colgate's (CL) robust innovation and expansion plans are likely to drive growth in the long term.
Is Colgate-Palmolive (CL) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Colgate-Palmolive (CL) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Want Better Returns? Don?t Ignore These 2 Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
The Zacks Analyst Blog Highlights McDonald's, Deere, Marsh & McLennan, Uber Technologies and Colgate-Palmolive
by Zacks Equity Research
McDonald's, Deere, Marsh & McLennan, Uber Technologies and Colgate-Palmolive are included in this Analyst Blog.
Top Stock Reports for McDonald's, Deere & Marsh & McLennan
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including McDonald's Corporation (MCD), Deere & Company (DE) and Marsh & McLennan Companies, Inc. (MMC).
Clorox (CLX) Beats Q3 Earnings & Sales Estimates, Ups View
by Zacks Equity Research
Clorox's (CLX) Q3 results reflect gains from a solid product pipeline, improved pricing, cost savings and strong execution, offset by lower volume and higher commodity costs.
Are You Looking for a Top Momentum Pick? Why Colgate-Palmolive (CL) is a Great Choice
by Zacks Equity Research
Does Colgate-Palmolive (CL) have what it takes to be a top stock pick for momentum investors? Let's find out.
The Zacks Analyst Blog Highlights PepsiCo, General Mills and Colgate-Palmolive
by Zacks Equity Research
PepsiCo, General Mills and Colgate-Palmolive are included in this Analyst Blog.
3 Consumer Staples Stocks Investors Shouldn't Ignore
by Derek Lewis
For those interested in a more conservative approach in the near-term with a Fed decision looming, these three low-beta stocks could be great considerations. Impressively, all are coming off a recent double-beat.
Zacks.com featured highlights ColgatePalmolive, BigCommerce and Exact Sciences
by Zacks Equity Research
ColgatePalmolive, BigCommerce and Exact Sciences have been highlighted in this Screen of The Week article.
Colgate (CL) Q1 Earnings & Sales Beat Estimates, View Up
by Zacks Equity Research
On an organic basis, Colgate-Palmolive's (CL) first-quarter 2023 sales advance 10%, with improvements in all divisions and categories.
Colgate-Palmolive (CL) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 4.29% and 3.30%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
3 Top Earnings Acceleration Stocks Worth Buying
by Tirthankar Chakraborty
Notable companies to have witnessed solid earnings acceleration as of now are ColgatePalmolive (CL), BigCommerce (BIGC) & Exact Sciences (EXAS).
Sysco Corporation (SYY) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Sysco (SYY) third-quarter results might reflect gains from the improving supply-chain efforts, and customer-oriented merchandising and marketing solutions.
Here's Why Clorox (CLX) Looks Well-Placed for Q3 Earnings Beat
by Zacks Equity Research
Clorox's (CLX) Q3 results are likely to reflect gains from strong demand, cost savings, improved productivity and pricing actions. The company's IGNITE strategy also bodes well.
Should You Buy Colgate (CL) Ahead of Earnings?
by Zacks Equity Research
Colgate (CL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Church & Dwight (CHD) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Church & Dwight (CHD) delivered earnings and revenue surprises of 11.84% and 5.73%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Here's How Colgate (CL) is Poised Ahead of Q1 Earnings
by Zacks Equity Research
Colgate's (CL) first-quarter 2023 sales are likely to have gained from innovation, brand strength, focus on premiumization and expansion efforts.